In vitro and in vivo studies of natural products: A challenge for their valuation. The case study of chamomile (Matricaria recutita L.)

Industrial Crops and Products

Volumn 40, Issue 1, 2012, Pages 1-12

  Petronilho, Sílvia ^a   Maraschin, Marcelo ^b   Coimbra, Manuel A ^a   Rocha, Sílvia M ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Biological activities; Chamomile; In vitro studies; In vivo studies; Sesquiterpenic compounds

Indexed keywords

ANIMAL STUDIES; CHAMOMILE; DEEP KNOWLEDGE; DEEP SURVEY; GENERAL PUBLICS; HEALTH BENEFITS; HUMAN HEALTH; IN-VITRO; IN-VIVO; INFORMATION CONCERNING; MEDICINAL PLANTS; NATURAL PRODUCTS; POTENTIAL HEALTH; SESQUITERPENIC COMPOUNDS; SIDE EFFECT; SPECIFIC EFFECTS;

BIOACTIVITY; PLANTS (BOTANY); RESEARCH;

PUBLIC HEALTH;

BIOACTIVITY; DATA SET; HEALTH IMPACT; HERB; MEDICINAL PLANT; NUMERICAL MODEL; PLANT EXTRACT; TERPENE;

ANIMALIA; MATRICARIA; MATRICARIA RECUTITA;

EID: 84858837680     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2012.02.041     Document Type: Review

References (96)

1. Alabaster V. In Vivo Pharmacology Training Group. The fall and rise of in vivo pharmacology. Trends Pharmacol. Sci. 2002, 23:13-18.
2. Albring M., Albrecht H., Alcorn G., Lüker P.W. The measuring of the anti-inflammatory effect of a compound on the skin of volunteers. Meth. Find. Exp. Clin. Pharmacol. 1983, 5:75-77.
3. Ansarullah R.N.J., Thounaojam M.C., Patel V., Devkar R.V., Ramachandran A.V. Antihyperlipidemic potential of a polyherbal preparation on triton WR 1339 (Tyloxapol) induced hyperlipidemia: a comparison with lovastatin. Int. J. Green Pharm. 2009, 3:119-124.
4. Avallone R., Zanoli P., Puia G., Kleinschnitz M., Schreier P., Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem. Pharmacol. 2000, 59:1387-1394.
5. Baser K.H., Demirci B., Iscan G., Hashimoto T., Demirci F., Noma Y., Asakawa Y. The essential oil constituents and antimicrobial activity of Anthemis aciphylla BOISS. var. discoidea BOISS. Chem. Pharm. Bull. (Tokyo) 2006, 54:222-225.
6. + ATP channels. J. Med. Food 2009, 12:1403-1406.
7. Bhaskaran N., Shukla S., Srivastava J.K., Gupta S. Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int. J. Mol. Med. 2010, 26:935-940.
8. Braga P.C., Dal Sasso M., Fonti E., Culici M. Antioxidant activity of bisabolol: inhibitory effects on chemiluminescence of human neutrophil bursts and cell-free systems. Pharmacology 2009, 83:110-115.
9. Brehm-Stecher B.F., Johnson E.A. Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol and apritone. Antimicrob. Agents Chemother. 2003, 47:3357-3360.
10. Briskin D.P. Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. Plant Physiol. 2000, 124:507-514.
11. Cavalieri E., Mariotto S., Fabrizi C., Carcereri de Prati A., Gottardo R., Leone S., Berra L.V., Lauro G.M., Ciampa A.R., Suzuki H. α-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells. Biochem. Biophys. Res. Commun. 2004, 315:589-594.
12. Chandrasekaran C.V., Sundarajan K., Kripalini D., Agarwal A. In vitro efficacy and safety of poly-herbal formulations. Toxicol. In Vitro 2010, 24:885-897.
13. Crotteau C.A., Wright S.T., Eglash A. Clinical inquiries: what is the best treatment for infants with colic?. J. Fam. Pract. 2006, 55:634-636.
14. Cushnie T.P.T., Lamb A.J. Review: antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26:343-356.
15. Davila J.C., Rodriguez R.J., Melchert R.B., Acosta D. Predictive value of in vitro model systems in toxicology. Annu. Rev. Pharmacol. Toxicol 1998, 38:63-96.
16. Della Loggia R., Carle R., Sosa S., Tubaro A. Evaluation of the anti-inflammatory activity of chamomile [Chamomilla recutita] preparations. Planta Med. 1990, 56:657-658.
17. Di Stasi L.C., Oliveira G.P., Carvalhaes M.A., Queiroz-Junior M., Tiena O.S., Kakinamia S.H., Reis M.S. Medicinal plants popularly used in the Brazilian Tropical Atlantic Forest. Fitoterapia 2002, 73:69-91.
18. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. Off. J. Eur. Union: L183 2002, 12(July):51-57.
19. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community Code relating to medicinal products for human use. Off. J. Eur. Union: L183 2004, 51(April):85-90.
20. Dragland S., Senoo H., Wake K., Holte K., Blomhoff R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J. Nutr. 2003, 133:1286-1290.
21. Fontanarosa P.B., Lundberg G.D. Alternative medicine meets science. J. Am. Med. Assoc. 1998, 280:1618-1619.
22. Forster H.B., Niklas H., Lutz S. Antispasmodic effects of some medicinal plants. Planta Med. 1980, 40:309-319.
23. Franke R., Schilcher H. Chamomile: Industrial Profiles, II Series: Medicinal and Aromatic Plants 2005, vol. 42. CRC Press/Taylor & Francis Group, Boca Raton/Broken Sound Parkway, NW.
24. Ganzera M., Schneider P., Stuppner H. Inhibition effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes. Life Sci. 2006, 78:856-861.
25. Gardiner P. Complementary, holistic, and integrative medicine: chamomile. Pediatr. Rev. 2007, 28:16-18.
26. Goeters S., Imming P., Pawlitzki G., Hempel B. On the absolute configuration of matricin. Planta Med. 2001, 67:292-294.
27. Gomes-Carneiro M.R., Dias D.M.M., De-Oliveira A.C.A.X., Paumgartten F.J.R. Evaluation of mutagenic and antimutagenic activities of α-bisabolol in the Salmonella/microsome assay. Mutat. Res. 2005, 585:105-112.
28. Gould L., Reddy C.V., Gomprecht R.F. Cardiac effects of chamomile tea. J. Clin. Pharmacol. 1973, 11:475-479.
29. Habersang S., Leuschner F., Isaac O., Thiemer K. Pharmacological studies with compounds of chamomile. IV. Studies on toxicity of (-)-alpha-bisabolol. Planta Med. 1979, 37:115-123.
30. 2-extract from German chamomile-proposed medicinal use. Acta Hortic. 1999, 503:15-19.
31. Hernández-Ceruelos A., Madrigal-Bujaidar E., de la Cruz C. Inhibitory effect of chamomile essential oil on the sister chromatid exchanges induced by daunorubicin and methyl methanesulfonate in mouse bone marrow. Toxicol. Lett. 2002, 135:103-110.
32. Hernández-Ceruelos A., Madrigal-Santillán E., Morales-González J.A., Chamorro-Cevallos G., Cassani-Galindo M., Madrigal-Bujaidar E. Antigenotoxic effect of Chamomilla recutita (L.) Rauschert essential oil in mouse spermatogonial cells and determination of its antioxidant capacity in vitro. Int. J. Mol. Sci. 2010, 11:3793-3802.
33. Imming P., Goeters S., Pawlitzki G., Hempel B. Absolute stereochemistry of guaianolides, of matricin and its epimers, of yarrow proazulenes, and of chamazulene carboxylic acid. Chirality 2001, 13:337-341.
34. Isaac O. Pharmacological investigation with compounds of chamomile on the pharmacology of (-)-alpha-bisabolol and bisabololoxides. Planta Med. 1979, 35:118-124. (review).
35. Kamatou G.P.P., Viljoen A.M. A review of the application and pharmacological properties of α-bisabolol and α-bisabolol-rich oils. J. Am. Oil Chem. Soc. 2010, 87:1-7.
36. Kassi E., Papoutsi Z., Fokialakis N., Messari I., Mitakou S., Moutsatsou P. Greek plant extracts exhibit selective estrogen receptor modulator (SERM)-like properties. J. Agric. Food Chem. 2004, 52:6956-6961.
37. Kintzios S., Michaelakis A. Induction of somatic embryogenesis and in vitro flowering from inflorescences of chamomile (Chamomilla recutita L.). Plant Cell Rep. 1999, 18:684-690.
38. Koleckar V., Opletal L., Brojerova E., Rehakova Z., Cervenka F., Kubikova K., Kuca K., Jun D., Polasek M., Kunes J., Jahodar L. Evaluation of natural antioxidants of Leuzea carthamoides as a result of a screening study of 88 plant extracts from the European Asteraceae and Cichoriaceae. J. Enzyme Inhib. Med. Chem. 2008, 23:218-224.
39. Korting H.C., Schafer-Korting M., Hart H., Laux P., Schmid M. Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose. Eur. J. Clin. Pharmacol. 1993, 44:315-318.
40. Kroll U., Cordes C. Pharmaceutical prerequisites for a multi-target therapy. Phytomedicine 2006, 5:12-19.
41. Lee K.G., Shibamoto T. Determination of antioxidant potential of volatile extracts isolated from various herbs and spices. J. Agric. Food. Chem. 2002, 50:4947-4952.
42. Leite G.O., Leite L.H.I., Sampaio R.S., Araruna M.K.A., Menezes I.R.A., Costa J.G.M., Campos A.R. (-)-α-Bisabolol attenuates visceral nociception and inflammation in mice. Fitoterapia 2011, 82:208-211.
43. Lemberkovics E., Kéry A., Marczal G., Simándi B., Szöke E. Phytochemical evaluation of essential oils, medicinal plants and their preparations. Acta Pharm. Hung. 1998, 68:141-149.
44. Lis-Balchin M., Deans S.G., Eaglesham E. Relationship between bioactivity and chemical composition of commercial essential oils. Flavour Frag. J. 1998, 13:98-104.
45. Lodish H., Berk A., Matsudaira P., Kaiser C.K., Krieger M., Scott M.P., Zipursky S.L., Darnell J. Molecular Cell Biology 2004, WH Freeman and Company, New York. 5th ed.
46. Lopes N.P., Kato M.J., Andrade E.H., Maia J.G., Yoshida M., Planchart A.R., Katzin A.M. Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol) Warb. by Waiapi Amazon Indians. J. Ethnopharmacol. 1999, 67:313-319.
47. Maiche A.G., Grohn P., Maki-Hokkonen H. Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol. 1991, 30:395-396.
48. Mainville I., Arcand Y., Farnworth E.R. A dynamic model that simulates the human upper gastrointestinal tract for the study of probiotics. Int. J. Food Microb. 2005, 99:287-296.
49. Maliakal P.P., Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J. Pharm. Pharmacol. 2001, 53:1323-1329.
50. Mann C., Staba E.J. In herbs, spices and medicinal plants: recent advances in botany. Horticulture and Pharmacology 1986, 235-280. Oryx Press, Phoenix, Arizona. L.E. Craker, J.E. Simon (Eds.).
51. Maschi O., Dal Cero E., Galli G.V., Caruso D., Bosisio E., Dell'Agli M. Inhibiton of human cAMP-phosphodiesterase as a mechanism of spasmolytic effect of Matricaria recutita L. J. Agric. Food Chem. 2008, 56:5015-5020.
52. Mckay D.L., Blumberg J.B. A review of the bioactive and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother. Res. 2006, 20:519-530.
53. Miller T., Wittstock U., Lindequist U., Teuscher E. Effects of some components of the essential oil of chamomile, Chamomilla recutita, on histamine release from rat mast cells. Planta Med. 1996, 62:60-61.
54. Milner J.A. Functional foods and health promotion. J. Nutr. 1999, 129:1395S-1397S.
55. Mohammad R., Hamida S., Adams An Norbert De K., Patrick V.D. Effects of planting date and seedling age on agro-morphological characteristics, essential oil content and composition of German chamomile (Matricaria chamomilla L.) grown in Belgium. Ind. Crops Prod. 2010, 31:145-152.
56. Nakamura H., Moriya K., Oda S., Yano E., Kakuta H. Changes in the parameters of autonomic nervous system and emotion spectrum calculated from encephalogram alter drinking chamomile tea. Aroma Res. 2002, 3:251-255. (Japanese).
57. Novakofski J. Adipogenesis: usefulness of in vitro and in vivo experimental models. J. Anim. Sci. 2004, 82:905-915.
58. Oehler Ch., Bensdorf K., Gust R., Imming P. Chamavioline-antiedematous, but not a constituent of Matricaria recutita. Phytochem. Lett. 2009, 2:171-175.
59. Ogata I., Kawanai T., Hashimoto E., Nishimura Y., Oyama Y., Seo H. Bisabololoxide A, one of the main constituents in German chamomile extract, induces apoptosis in rat thymocytes. Arch. Toxicol. 2010, 84:45-52.
60. Orav A., Kailas T., Ivask K. Volatile constituents of Matricaria recutita L. from Estonia. Proc. Estonian Acad. Sci. Chem. 2001, 50:39-45.
61. Pascual C., Karzai W., Meier-Hellmann A., Bredle D.L., Reinhart K. A controlled study of leukocyte activation in septic patients. Intensive Care Med. 1997, 23:743-748.
62. Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise. Int. J. Oncol. 2007, 30:233-245. (review).
63. ® cream in atopic eczema. Eur. J. Med. Res. 2000, 5:171-175.
64. Petronilho S., Maraschin M., Delgadillo I., Coimbra M.A., Rocha S.M. Sesquiterpenic composition of the inflorescences of Brazilian chamomile (Matricaria recutita L.). Impact of the agricultural practices. Ind. Crops Prod. 2011, 34:1482-1490.
65. Pierre S., Crosbie L., Duttaroy A.K. Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro. Platelets 2005, 16:469-473.
66. 2 extraction of essential oil and oleoresin from chamomile (Chamomilla recutita [L.] Rauschert). J. Supercrit. Fluids 2001, 21:245-256.
67. Presibella M.M., Santos C.A., Weffort-Santos A.M. In vitro antichemotactic activity of Chamomilla recutita hydroethanol extract. Pharm. Biol. 2007, 45:124-130.
68. Presibella M.M., Villas-Bôas L.B., Belletti K.M.S., Santos C.A.M., Weffort-Santos A.M. Comparison of chemical constituents of Chamomilla recutita (L.) Rauschert essential oil and its anti-chemotactic activity. Braz. Arch. Biol. Technol. 2006, 49:717-724.
69. Rahimia E., Pradob J.M., Zahedic G., Meireles M.A.A. Chamomile extraction with supercritical carbon dioxide: mathematical modeling and optimization. J. Supercrit. Fluids 2011, 56:80-88.
70. Ramadan M., Goeters S., Watzer B., Krause E., Lohmann K., Bauer R., Hempelr B., Imming P. Chamazulene carboxylic acid and matricin: a natural profen and its natural prodrug, identified through similarity to synthetic drug substances. J. Nat. Prod. 2006, 69:1041-1045.
71. Rekka E.A., Kourounakis A.P., Kourounakis P.N. Investigation of the effect of chamazulene on lipid peroxidation and free radical process. Res. Commun. Mol. Pathol. Pharmacol. 1996, 92:361-364.
72. Rocha N.F.M., Venâncio E.T., Moura B.A., Silva M.I.G., Neto M.R.A., Riosa E.R.V., Sousa D.P., Vasconcelos S.M.M., Fonteles M.M.F., Sousa F.C.F. Gastroprotection of (-)-α-bisabolol on acute gastric mucosal lesions in mice: the possible involved pharmacological mechanisms. Fundam. Clin. Pharmacol. 2010, 24:63-71.
73. Rocha S.M., Coelho E., Vinholes J., Coimbra M.A. Grapes and wine from Vitis vinifera L. as a potential source of sesquiterpenoids. Natural Products, Series Recent Progress in Medicinal Plants 2006, vol. 15:253-272. Studium Press LLC, Huston, TX, USA, (Cap 12).
74. Rodriguez-Fragoso L., Reyes-Esparza J., Burchiel S.W., Herrera-Ruiz D., Torres E. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol. Appl. Pharmacol. 2008, 227:125-135.
75. Rubiolo P., Belliardo F., Cordero C., Liberto E., Sgorbini B., Bicchi C. Headspace-solid-phase microextraction fast GC in combination with principal component analysis as a tool to classify different chemotypes of chamomile flower-heads (Matricaria recutita L.). Phytochem. Anal. 2006, 17:217-225.
76. Safayhi H., Sabieraj J., Sailer E.R., Ammon H.P. Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation. Planta Med. 1994, 60:410-413.
77. Salamon I., Honcariv R. Growing condition and breeding of chamomile (Chamomilla recutita L.) Rauschert regarding the essential oil qualitative-quantitative characterization in Slovakia. Herba Pol. 1994, 68-74.
78. Salamon I. Effect of the internal and external factors on yield and qualitative-quantitative characteristics of chamomile essential oil. Acta Hortic. 2007, 749:45-64.
79. Schneeman B. FDA's review of scientific evidence for health claims. J. Nutr. 2007, 137:493-494.
80. Shikov A.N., Pozharitskaya O.N., Makarov V.G., Kvetnaya A.S. Antibacterial activity of Chamomilla recutita oil extract against Helicobacter pylori. Phytother. Res. 2008, 22:252-253.
81. Simões M., Rocha S., Coimbra M.A., Vieira M.J. Enhancement of Escherichia coli and Staphylococcus aureus antibiotic susceptibility using sesquiterpenoids. Med. Chem. 2008, 4:616-623.
82. Soliman K.M., Badeaa R.I. Effect of oil extracted from some medicinal plants on different mycotoxigenic fungi. Food Chem. Toxicol. 2002, 40:1669-1675.
83. Srivastava J.K., Gupta S. Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J. Agric. Food Chem. 2007, 55:9470-9478.
84. Srivastava J.K., Pandey M., Gupta S. Chamomile, a novel and selective Cox-2 inhibitor with anti-inflammatory activity. Life Sci. 2009, 85:663-669.
85. Srivastava J.K., Shankar E., Gupta S. Chamomile: a herbal medicine of the past with bright future. Mol. Med. Rep. 2010, 3:895-901.
86. Stamatis G., Kyriazopoulos P., Golegou S., Basayiannis A., Skaltsas S., Skaltsa H. In vitro anti-Helicobacter pylori activity of Greek herbal medicines. J. Ethnopharmacol. 2003, 88:175-179.
87. Syracuse Research Corporation The Physical Properties Database 2010, Available at: http://www.syrres.com/esc/physdemo.htm (accessed 07.06.10).
88. Szelenyi I., Isaac O., Thiemer K. Pharmacological experiments with compounds of chamomile. III. Experimental studies of the ulcerprotective effect of chamomile. Planta Med. 1979, 35:218-227.
89. Szoke É., Máday E., Gershenzon J., Lemberkovics É. Terpenoids in genetically transformed cultures of chamomile. Chromatographia 2004, 60:S269-S272.
90. Szoke É., Máday E., Tyihák E., Kuzovkina I.N., Lemberkovics É. New terpenoids in cultivated and wild chamomile (in vivo and in vitro). J. Chromatogr. B 2004, 800:231-238.
91. Torrado S., Torrado S., Agis A., Jiménez M.E., Cadorniga R. Effect of dissolution profile and (-)-alpha-bisabolol on the gastrotoxicity of acetylsalicylic acid. Pharmazie 1995, 50:141-143.
92. Tubaro A., Zilli C., Redaelli C., Della Loggia R. Evaluation of antiinflammatory activity of a chamomile extract after topical application. Planta Med. 1984, 50:359.
93. Van der Kooy F., Maltese F., Choi Y.H., Kim H.K., Verpoorte H. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. Planta Med. 2009, 75:763-775.
94. van Zyl R.L., Seatlholo S.T., van Vuuren S.F., Viljoen A.M. The biological activities of 20 nature identical essential oil constituents. J. Essent. Oil Res. 2006, 18:129-133.
95. Yarosh D.B., Galvin J.W., Nay S.L., Pena A.V., Canning M.T., Brown D.A. Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine. J. Dermatol. Sci. 2006, 42:13-21.
96. Yuan R., Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol. Ther. 2000, 86:191-198.